HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission.

AIDS. 1991 Sep;5(9):1111-6. Unique Identifier : AIDSLINE MED/92029729
Lindgren S; Anzen B; Bohlin AB; Lidman K; Department of Obstetrics and Gynecology, Huddinge Hospital,; Stockholm, Sweden.

Abstract: Forty-four HIV-1-seropositive women and their children were followed-up and examined in connection with the course of pregnancy, mother-to-infant transmission of HIV and clinical outcome. Twelve out of 48 children were known to be infected and two children were lost to follow-up. Of the remaining 34 children, 22 are not infected, and 12 are clinically and immunologically normal at less than 18 months. There was no difference in intrauterine growth between infected and uninfected children. Forty-six per cent of the 39 mothers seen after delivery progressed to a more advanced stage of HIV infection during a mean follow-up time of 33 months after delivery. Although comparable in age, clinical and immunological status at delivery, and follow-up time, mothers of infected children had longer durations of HIV infection and were symptomatic and/or had low CD4 cell counts to a significantly greater extent at follow-up than mothers of uninfected children.
Keywords: Child, Preschool Female Follow-Up Studies Human HIV Infections/*TRANSMISSION *HIV-1 Infant Infant, Newborn Male Pregnancy *Pregnancy Complications, Infectious Pregnancy Outcome Risk Factors Support, Non-U.S. Gov't Sweden JOURNAL ARTICLEKWDchild,preschoolfemalefollow-upstudieshumanhivinfections/KWDtransmissionKWDhiv-1infantinfant,newbornmalepregnancyKWDpregnancycomplications,infectiouspregnancyoutcomeriskfactorssupport,non-uKWDsKWDgov'tswedenjournalarticle
920228
M9220835

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .